Aligos Therapeutics Inc (ALGS)

Jun 07, 2026

Aligos Therapeutics (ALGS) Slides 8% – Support Test on the Horizon?Factor Rotation - newsline.com

Jun 07, 2026

Jun 05, 2026

Aligos Therapeutics Inc (ALGS) Stock Price, Quote, News & History - Benzinga

Jun 05, 2026

Jun 01, 2026

Lake Street Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $45 - Moomoo

Jun 01, 2026

May 30, 2026

Aligos Therapeutics (ALGS) Gets a Buy from Cantor Fitzgerald - The Globe and Mail

May 30, 2026

May 29, 2026

How (ALGS) Movements Inform Risk Allocation Models - Stock Traders Daily

May 29, 2026

May 29, 2026

Cantor Fitzgerald reiterates Aligos stock Overweight on HBV data By Investing.com - Investing.com Nigeria

May 29, 2026

May 29, 2026

Aligos’ ALG-215007 candidate ASO for HDV infection - BioWorld News

May 29, 2026

May 29, 2026

Cantor Fitzgerald reiterates Aligos stock Overweight on HBV data - Investing.com

May 29, 2026

May 29, 2026

Lake Street Initiates Aligos Therapeutics(ALGS.US) With Buy Rating, Announces Target Price $45 - Moomoo

May 29, 2026

May 28, 2026

ALGS Initiated Coverage by Lake Street -- Price Target Announced at $45 - GuruFocus

May 28, 2026

May 28, 2026

Aligos Therapeutics stock initiated at Buy by Lake Street on HBV drug potential - Investing.com South Africa

May 28, 2026

May 27, 2026

Aligos Therapeutics (ALGS) Showcases Promising Data at EASL Cong - GuruFocus

May 27, 2026

May 27, 2026

Hepatitis B data: 40% on Aligos drug reach HBsAg level used for cure regimens - Stock Titan

May 27, 2026

May 27, 2026

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 - Investing News Network

May 27, 2026

May 27, 2026

Aligos Therapeutics Presents Positive Phase 1 Data for Pevifoscorvir Sodium at EASL Congress 2026, Suggesting Reduced cccDNA Reservoir in Chronic HBV Patients - Quiver Quantitative

May 27, 2026

May 27, 2026

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 - GlobeNewswire Inc.

May 27, 2026

May 24, 2026

ALGS Q1 2026 Earnings: Narrower-Than-Expected Loss as Aligos Therapeutics Advances PipelineRevenue Estimate Trend - newsline.com

May 24, 2026

May 21, 2026

Cantor Fitzgerald Initiates Aligos Therapeutics(ALGS.US) With Buy Rating, Announces Target Price $20 - Moomoo

May 21, 2026

May 21, 2026

ALGS Initiated Coverage by Cantor Fitzgerald -- Rating Set to Ov - GuruFocus

May 21, 2026

May 20, 2026

ALGS News | ALIGOS THERAPEUTICS INC (NASDAQ:ALGS) - ChartMill

May 20, 2026

May 15, 2026

Lawrence M. Blatt discloses 5.1% stake in Aligos Therapeutics (ALGS) - Stock Titan

May 15, 2026

May 15, 2026

Aligos (ALGS) Delivers Q1 2026 Beat — EPS $-2.21 vs $-2.27 ExpectedSocial Trade Signals - Newser

May 15, 2026

May 15, 2026

Woodline Partners reports 4.4% stake in Aligos Therapeutics (NASDAQ: ALGS) - Stock Titan

May 15, 2026

May 13, 2026

Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 - The Manila Times

May 13, 2026

May 13, 2026

Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at EASL Congress 2026 - Quiver Quantitative

May 13, 2026

May 13, 2026

Liver disease drug data: Aligos secures 10 EASL 2026 slots - Stock Titan

May 13, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 09, 2026

What you need to know before buying Aligos (ALGS) (Investor Concern) 2026-05-08Crowd Consensus Signals - newser.com

May 09, 2026

May 08, 2026

The operating leverage hidden in Aligos (ALGS) results | Q1 2026: EPS Exceeds ExpectationsTarget Revision - Newser

May 08, 2026

May 07, 2026

Aligos Therapeutics (NASDAQ:ALGS) Surges After Hours on Q1 Earnings Beat - ChartMill

May 07, 2026

May 07, 2026

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results - Investing News Network

May 07, 2026

May 07, 2026

China HBV license adds cash as Aligos (NASDAQ: ALGS) faces going‑concern risk - Stock Titan

May 07, 2026

May 07, 2026

Aligos lands FDA Fast Track and a $25M China deal for HBV drug - Stock Titan

May 07, 2026

May 07, 2026

Earnings Preview: ALGS to Report Financial Results Post-market on May 07 - Moomoo

May 07, 2026

May 07, 2026

How Aligos Therapeutics Inc. (ALGS) Affects Rotational Strategy Timing - Stock Traders Daily

May 07, 2026

May 05, 2026

Aligos Therapeutics Inc expected to post a loss of $2.22 a shareEarnings Preview - TradingView

May 05, 2026

May 01, 2026

Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026 - The Manila Times

May 01, 2026

Apr 30, 2026

Biotech Aligos will post first-quarter results after markets close May 7 - Stock Titan

Apr 30, 2026

Apr 29, 2026

[ARS] Aligos Therapeutics, Inc. SEC Filing - Stock Titan

Apr 29, 2026

Apr 29, 2026

Aligos Therapeutics says China pact puts HBV drug in focus amid trial updates - MSN

Apr 29, 2026

Apr 29, 2026

Aligos Therapeutics (Nasdaq: ALGS) details ESPP, auditor and pay votes - Stock Titan

Apr 29, 2026

Apr 28, 2026

Aligos’ licensing deal in China broadens trial scope, secures immediate $25m - MLex

Apr 28, 2026

Apr 27, 2026

Is Aligos (ALGS) overbought or oversold? (Drifts Higher) 2026-04-27Retail Flow - Newser

Apr 27, 2026

Apr 27, 2026

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Apr 27, 2026